These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 1833315)

  • 41. Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes.
    Conti P; Panara MR; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Agents Actions; 1992; Spec No():C93-5. PubMed ID: 1332453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of biological response modifiers on lung natural killer activity.
    Lauzon W; Lemaire I
    Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.
    Hansen ML; Woetmann A; Krejsgaard T; Kopp KL; Søkilde R; Litman T; Straten PT; Geisler C; Wasik MA; Odum N; Eriksen KW
    Mol Immunol; 2011 Sep; 48(15-16):2087-93. PubMed ID: 21813181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific inhibition of interleukin 1 beta gene expression by an antisense oligonucleotide: obligatory role of interleukin 1 in the generation of lymphokine-activated killer cells.
    Fujiwara T; Grimm EA
    Cancer Res; 1992 Sep; 52(18):4954-9. PubMed ID: 1387585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation by lipopolysaccharide of inflammatory cytokine production by two T cell lines.
    Uchimura E; Watanabe N; Kobayashi Y
    Cytokine; 1997 Oct; 9(10):727-33. PubMed ID: 9344503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human mesangial cells synthesize interleukin 1 alpha but not interleukin 1 beta, interleukin 1 receptor antagonist, or tumour necrosis factor.
    Abbott F; Tam FW; Ryan JJ; Rees AJ
    Nephrol Dial Transplant; 1992; 7(10):997-1001. PubMed ID: 1331895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
    Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M
    Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
    Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation.
    Loughlin AJ; Woodroofe MN; Cuzner ML
    Immunology; 1992 Jan; 75(1):170-5. PubMed ID: 1537593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
    Cordero OJ; Sarandeses CS; López JL; Nogueira M
    Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
    D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
    J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures.
    Conti P; Panara MR; Barbacane RC; Placido FC; Bongrazio M; Reale M; Dempsey RA; Fiore S
    Cell Immunol; 1992 Nov; 145(1):199-209. PubMed ID: 1330330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impairment of cytokine production in mice fed a vitamin D3-deficient diet.
    Kankova M; Luini W; Pedrazzoni M; Riganti F; Sironi M; Bottazzi B; Mantovani A; Vecchi A
    Immunology; 1991 Aug; 73(4):466-71. PubMed ID: 1655638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity.
    Reiter Z; Chen L; Revel M; Rubinstein M
    Lymphokine Cytokine Res; 1992 Jun; 11(3):175-81. PubMed ID: 1327193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo.
    Faherty DA; Claudy V; Plocinski JM; Kaffka K; Kilian P; Thompson RC; Benjamin WR
    J Immunol; 1992 Feb; 148(3):766-71. PubMed ID: 1530956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion.
    Ziegler-Heitbrock HW; Blumenstein M; Käfferlein E; Kieper D; Petersmann I; Endres S; Flegel WA; Northoff H; Riethmüller G; Haas JG
    Immunology; 1992 Feb; 75(2):264-8. PubMed ID: 1551689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.